European Commission logo
English English
CORDIS - EU research results
CORDIS

“MICROMETABOLITE” – Research Training Network on the Microbial Enhancement of Bioactive Secondary Metabolite Production in Plants

Project description

Innovative plant production system

Plant-associated microorganisms, including bacteria and fungi play a vital role in plant health and secondary metabolite synthesis. Understanding the interplay between host plants and their associated microorganisms can help enhance the production of bioactive compounds for medicinal and cosmetic purposes. Funded by the Marie Skłodowska-Curie Actions programme, the MICROMETABOLITE project aims to investigate how microorganisms influence metabolite production and establish novel production systems for naphtoquinone derivatives known for their anti-inflammatory properties and role in tissue regeneration. The project will also train young scientists to lead future advancements in pharmaceutical and cosmeceutical applications.

Objective

Plant-derived natural products or, more specifically, plant secondary metabolites are backbones of today’s pharmaceutical and cosmeceutical industry. Plant-associated microorganisms have been implicated an important role in sustaining plant growth and, through inducing or influencing synthesis pathways, in the production of plant secondary metabolites. MICROMETABOLITE aims at exploring the plant-associated microflora for improving the production of bioactive secondary plant metabolites that are of high value for industrial applications. The network will focus on members of the Boraginaceae plant family including Lithospermum and Alkanna species, which produce the naphtoquinones shikonin and alkannin derivatives (A/S). These plants are used for the production of several pharmaceutical and cosmeceutical preparations that are already on the market or in the final stages of development. Specifically, we will analyse relationships between the content of A/S or other secondary metabolites, the plant genotype, and the plant-associated microflora. Further, we will explore in which ways microorganisms beneficially influence metabolite production, and we will establish novel production systems, enabling that raw materials for industrial applications can be cultivated under Good Agricultural Practices (GAP).
MICROMETABOLITE aspires to create an environment that will foster synergistic cooperation between researchers in relevant, currently hardly inter-linked scientific disciplines and maximize the exploitation of plant biotechnology in accordance with the needs of the European pharmaceutical and cosmetic industries. As the first network in this area, it will train some of the most talented European young scientists (ESRs) to become future leading scientists, technologists and entrepreneurs, who can take on leadership in the required scientific and technological discovery and in the development of next-generation pharmaceutical and cosmeceutical applications.

Coordinator

AIT AUSTRIAN INSTITUTE OF TECHNOLOGY GMBH
Net EU contribution
€ 511 868,16
Address
GIEFINGGASSE 4
1210 Wien
Austria

See on map

Region
Ostösterreich Wien Wien
Activity type
Research Organisations
Links
Total cost
€ 511 868,16

Participants (5)